NOX4 and Parkinson disease: By inhibiting NOX4 in a Parkinson’s disease (PD) model, these EVs can reduce the production of reactive oxygen species, thereby mitigating oxidative stress and its inflammatory consequences in dopaminergic neurons (He et al., 2023).